Volume 2, Issue 4 (October 2023)
Health Science Monitor 2023, 2(4): 225-232 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Kazempour Dizaji M, Emamhadi M A, Roozbahani R, Varahram M, Abedini A, Zare A, et al . Investigating the effect of health measures and social restrictions on the COVID-19 epidemic based on the SIQR mathematical model. Health Science Monitor 2023; 2 (4) :225-232
URL: http://hsm.umsu.ac.ir/article-1-104-en.html
URL: http://hsm.umsu.ac.ir/article-1-104-en.html
Mehdi Kazempour Dizaji * 
, Mohammad Ali Emamhadi , Rahim Roozbahani , Mohammad Varahram , Atefe Abedini , Ali Zare , Arda Kiani , Niloufar Alizedeh Kolahdozi , Syeyd Alireza Nadji , Majid Marjani
, Mohammad Ali Emamhadi , Rahim Roozbahani , Mohammad Varahram , Atefe Abedini , Ali Zare , Arda Kiani , Niloufar Alizedeh Kolahdozi , Syeyd Alireza Nadji , Majid Marjani
Mycobacteriology Research Center (MRC), National Research Institute of Tuberculosis and Lung Disease (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran (Corresponding Author)
Abstract: (919 Views)
Background & Aims: COVID-19 pandemic is a serious concern of the World Health Organization and is considered the most important global health challenge. This study aimed to study the effect of health measures and social restrictions on the COVID-19 epidemic based on the susceptible-infectious-quarantine-recovered (SIQR) mathematical model.
Materials & Methods: Using the SIQR model, we assessed the effect of health measures and social restrictions on the COVID-19 epidemic by considering different values for the reproductive rate parameter and constant values for the recovery rate and quarantined rate (or disease detection rate).
Results: The results indicated that with increasing the level of social restrictions and health measures equivalent to 20, 40, 60, and 80%, the reproductive rate of the COVID-19 reduced from 2.5 to 2, 1.5, 1, and 0.5, respectively. Also, with increasing the levels of social restrictions and health measures, a smaller percentage of people in the community became infected. Considering the level of social restrictions equal to 20, 40, 60, and 80% during the COVID-19 epidemic, about 60, 50, 35, and 10% of the individuals were infected with COVID-19, respectively.
Conclusion: The study of the impact of health measures and social restrictions on the COVID-19 epidemic will provide appropriate information on how the disease spreads and also help researchers select the proper level of these measures and restrictions to prevent further spread of COVID-19 disease.
Materials & Methods: Using the SIQR model, we assessed the effect of health measures and social restrictions on the COVID-19 epidemic by considering different values for the reproductive rate parameter and constant values for the recovery rate and quarantined rate (or disease detection rate).
Results: The results indicated that with increasing the level of social restrictions and health measures equivalent to 20, 40, 60, and 80%, the reproductive rate of the COVID-19 reduced from 2.5 to 2, 1.5, 1, and 0.5, respectively. Also, with increasing the levels of social restrictions and health measures, a smaller percentage of people in the community became infected. Considering the level of social restrictions equal to 20, 40, 60, and 80% during the COVID-19 epidemic, about 60, 50, 35, and 10% of the individuals were infected with COVID-19, respectively.
Conclusion: The study of the impact of health measures and social restrictions on the COVID-19 epidemic will provide appropriate information on how the disease spreads and also help researchers select the proper level of these measures and restrictions to prevent further spread of COVID-19 disease.
Keywords: COVID-19, Epidemic, Health measures, Mathematical modeling, SIQR model, Social restrictions
Type of Study: Research |
Subject:
General
Received: 2022/12/25 | Accepted: 2023/01/4 | Published: 2023/10/29
Received: 2022/12/25 | Accepted: 2023/01/4 | Published: 2023/10/29
References
1. Gao J, Tian Z, Yang X. Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies. Biosci Trends. 2020;14(1):72-73. doi:10.5582/bst.2020.01047. [DOI] [PMID]
2. Hui DS, Azhar EI, Madani TA, Ntoumi F, Kock R, Dar O, et al. The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - The latest 2019 novel coronavirus outbreak in Wuhan, China. Int J Infect Dis. 2020;91:264-266. doi:10.1016/j.ijid.2020.01.009. [DOI] [PMID] [PMCID]
3. COVID-19 Dashboard by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU). ArcGIS [Internet]. Johns Hopkins University; 2020 [cited 2020 May 26]. Available from: https://coronavirus.jhu.edu/map.html. [URL]
4. Roush S, Birkhead G, Koo D, Cobb L, Fleming D; Centers for Disease Control and Prevention (CDC). National Center for Immunization and Respiratory Diseases (NCIRD) Support for Modernization of the Nationally Notifiable Diseases Surveillance System (NNDSS) to Strengthen Public Health Surveillance Infrastructure in the US [abstract]. In: 2019 CSTE Annual Conference; 2019 Jun 2-6; Raleigh, NC. [URL]
5. World Health Organization (WHO). WHO Director-General's remarks at the media briefing on 2019-nCoV on 11 February 2020 [Internet]. Geneva: WHO; 2020 [cited 2020 Feb 11]. Available from: https://www.who.int/director-general/speeches/detail/who-director-general-s-remarks-at-the-media-briefing-on-2019-ncov-on-11-february-2020. [URL]
6. Maitra S, Biswas M, Bhattacharjee S. Case-fatality rate in COVID-19 patients: A meta-analysis of publicly accessible database [preprint]. medRxiv [Internet]. 2020 [cited 2020 May 26]. Available from: https://www.medrxiv.org/content/10.1101/2020.05.22.20109231v1. [DOI]
7. Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020;323(13):1239-1242. doi:10.1001/jama.2020.2648. [DOI] [PMID]
8. Mahase E. Coronavirus: covid-19 has killed more people than SARS and MERS combined, despite lower case fatality rate [news]. BMJ [Internet]. 2020 Feb 18 [cited 2020 May 26];368:m641. Available from: https://www.bmj.com/content/368/bmj.m641. [DOI] [PMID]
9. Guan W-j, Ni Z-y, Hu Y, Liang W-h, Ou C-q, He J-x, et al.; China Medical Treatment Expert Group for Covid-19. Clinical characteristics of coronavirus disease 2019 in China [published online ahead of print February 28, 2020]. N Engl J Med [Internet]. doi:10.1056/NEJMoa2002032. [DOI] [PMID] [PMCID]
10. Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, et al.; Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia Investigation Team*. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia [published online ahead of print January 29, 2020]. N Engl J Med [Internet]. doi:10.1056/NEJMoa2001316. [DOI] [PMID] [PMCID]
11. Chan JF-W, Yuan S, Kok K-H, To KK-W, Chu H, Yang J, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet. 2020;395(10223):514-523. doi:10.1016/S0140-6736(20)30154-9. [DOI] [PMID]
12. Li G, De Clercq E. Therapeutic options for the 2019 novel coronavirus (2019-nCoV). Nat Rev Drug Discov. 2020;19(3):149-150. doi:10.1038/d41573-020-00016-0. [DOI] [PMID]
13. Ahn JY, Sohn Y, Lee SH, Cho Y, Hyun JH, Baek YJ, et al. Use of convalescent plasma therapy in two COVID-19 patients with acute respiratory distress syndrome in Korea. J Korean Med Sci. 2020;35(14):e149. doi:10.3346/jkms.2020.35.e149. [DOI] [PMID] [PMCID]
14. Lu H. Drug treatment options for the 2019-new coronavirus (2019-nCoV). Biosci Trends. 2020;14(1):69-71. doi:10.5582/bst.2020.01020. [DOI] [PMID]
15. Tanne JH. Covid-19: FDA approves use of convalescent plasma to treat critically ill patients [news]. BMJ [Internet]. 2020 Mar 26 [cited 2020 May 26];368:m1256. Available from: https://www.bmj.com/content/368/bmj.m1256. [DOI] [PMID]
16. Nesteruk I. Estimations of the coronavirus epidemic dynamics in south korea with the use of sir model [preprint]. ResearchGate [Internet]. 2020 Mar [cited 2020 May 26]. Available from: https://www.researchgate.net/publication/339961786_Estimations_of_the_coronavirus_epidemic_dynamics_in_South_Korea_with_the_use_of_SIR_model. [URL]
17. Chen Y-C, Lu P-E, Chang C-S. A time-dependent SIR model for COVID-19 [preprint]. arXiv [Internet]. 2020 Mar 2 [cited 2020 May 26]. Available from: https://arxiv.org/abs/2003.00122. [URL]
18. Zhu K, Ying L. Information source detection in the SIR model: A sample-path-based approach. IEEE/ACM Trans Netw [Internet]. 2016 Feb;24(1):408-421. doi:10.1109/TNET.2014.2369495. [DOI]
19. Hethcote H, Zhien M, Shengbing L. Effects of quarantine in six endemic models for infectious diseases [abstract]. Math Biosci [Internet]. 2002 Jul;180(1-2):141-160. [DOI] [PMID]
20. Calafiore GC, Novara C, Possieri C. A modified SIR model for the COVID-19 contagion in Italy [preprint]. arXiv [Internet]. 2020 Mar 22 [cited 2020 May 26]. Available from: https://arxiv.org/abs/2003.14391. [DOI]
21. Peng L, Yang W, Zhang D, Zhuge C, Hong L. Epidemic analysis of COVID-19 in China by dynamical modeling [preprint]. arXiv [Internet]. 2020 Feb 15 [cited 2020 May 26]. Available from: https://arxiv.org/abs/2002.06563. [DOI]
22. COVID C. Global Cases by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University. Coronavirus Resource Center [Internet]. Johns Hopkins University; 2020 Mar 17 [cited 2020 May 26]. Available from: https://coronavirus.jhu.edu/map.html. [URL]
23. Coronavirus COVID-19 Global Cases by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU). ArcGIS [Internet]. Johns Hopkins University; 2020 [cited 2020 May 26]. Available from: https://gisanddata.maps.arcgis.com/apps/opsdashboard/index.html#/bda7594740fd40299423467b48e9ecf6. [URL]
24. Singh R, Adhikari R. Age-structured impact of social distancing on the COVID-19 epidemic in India [preprint]. arXiv [Internet]. 2020 Mar 26 [cited 2020 May 26]. Available from: https://arxiv.org/abs/2003.12055. [URL]
25. Rothe C, Schunk M, Sothmann P, Bretzel G, Froeschl G, Wallrauch C, et al. Transmission of 2019-nCoV infection from an asymptomatic contact in Germany. N Engl J Med. 2020;382(10):970-971. doi:10.1056/NEJMc2001468. [DOI] [PMID] [PMCID]
26. Kupferschmidt K. Study claiming new coronavirus can be transmitted by people without symptoms was flawed [news]. Science [Internet]. 2020 Feb 3 [cited 2020 May 26]. Available from: https://www.sciencemag.org/news/2020/02/paper-non-symptomatic-patient-transmitting-coronavirus-wrong [DOI]
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
